eClinicalMedicine – The Lancet Discovery Science
eclinicalmed.bsky.social
Gold #OpenAccess clinical #medical journal, part of The Lancet Discovery Science, influencing clinical practice and strengthening health. IF: 12·8; CiteScore: 17·3. 🌐 https://www.thelancet.com/journals/eclinm/home
👤 Joined on 13 February 2025
392
Followers
149
Following
253
Total Posts
📜 Kullanıcı Geçmişi
- 13 Şub 2025, 11:25
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@eclinicalmed.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Published in @eclinicalmed.bsky.social Weight loss & blood pressure lowering with #GLP-1 receptor agonists & multi-hormone receptor modulators in #overweight & #obesity: a systematic review & meta-regression of phase 3 clinical trials www.thelancet.com/journals/ecl... #OpenAccess #MedSky #EndoSky
Show PostIn @eclinicalmed.bsky.social Dose-dependent efficacy & renal safety of pemafibrate versus fenofibrate in patients with metabolic dysfunction-associated steatotic liver disease (#MASLD) & hypertriglyceridemia: a multicenter randomized controlled, open label trial www.thelancet.com/journals/ecl....
Show PostPublished in @eclinicalmed.bsky.social The lancet commission definition of #clinical #obesity: a multi-cohort cross-sectional analysis from early childhood to older age in seven high-income countries www.thelancet.com/journals/ecl... #OpenAccess #MedSky #EndoSky
Show PostPublished in @eclinicalmed.bsky.social Overnight metyrapone in mild autonomous cortisol secretion: a single-centre, single-arm, phase 2 trial www.thelancet.com/journals/ecl... #OpenAccess #MedSky #EndoSky
Show PostPublished in @eclinicalmed.bsky.social The effect of #SGLT2 inhibitors, #GLP-1 receptor agonists, or #DPP-4 inhibitors on #stroke risk in type 2 #diabetes: a nationwide longitudinal cohort study in Sweden with contextualisation analysis www.thelancet.com/journals/ecl... #T2D #OpenAccess #EndoSky
Show Post